INIS
patients
100%
nervous system diseases
64%
glioblastomas
48%
tumors
46%
symptoms
32%
reviews
31%
brain
27%
motors
19%
risks
17%
cancer
17%
values
17%
assessments
16%
sampling
14%
metastases
14%
levels
13%
diseases
12%
fluctuations
12%
nerves
12%
validation
12%
recovery
11%
gliomas
10%
nmr imaging
10%
therapy
10%
mutations
9%
populations
9%
sensitivity
9%
losses
9%
surgery
8%
feasibility studies
8%
muscles
8%
Keyphrases
Parkinson's Disease
56%
Glioblastoma
33%
Parkinson Patients
24%
Experience Sampling
16%
Neurofibromatosis Type 1 (NF-1)
14%
Neurofibromatosis Type I
13%
Malignant Peripheral Nerve Sheath Tumor (MPNST)
12%
Clinically Significant
10%
Motor Fluctuations
9%
Risk Factors
9%
Newly Diagnosed Glioblastoma
8%
Imaging Marker
8%
Hamilton Depression Rating Scale (HAM-D)
8%
Motor Symptoms
8%
Patients with Parkinson's Disease
8%
Validation Studies
8%
Temporal muscle Thickness
8%
Anxiety Disorders
8%
Non-small Cell Lung Cancer (NSCLC)
8%
Hospitalization
8%
Psychosis
8%
Temozolomide
8%
Prognostic Model
8%
Tumor
7%
Low-grade Glioma
6%
Depressive Symptoms
6%
Contextual Factors
6%
Meta-analysis
6%
VASARI Features
5%
Glioma
5%
Medicine and Dentistry
Glioblastoma
29%
Neoplasm
17%
Ganglioglioma
13%
Neurofibromatosis Type I
13%
Intracranial Tumor
12%
Malignant Peripheral Nerve Sheath Tumor
12%
Magnetic Resonance Imaging
11%
Radiation Therapy
8%
Quality of Life
6%
Metastatic Carcinoma
6%
Malignant Neoplasm
6%
Isocitrate Dehydrogenase
6%
Systematic Review
6%
Biopsy Technique
5%
